	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	704	832	816	730	1,030	1,345	1,587	2,039	2,213	774	653	189	4	-	54
Cost of Operating Revenue	272	311	330	259	368	483	561	728	829	303	268	100	4	-	54
Gross Profit	432	521	485	471	662	861	1,026	1,311	1,384	471	384	89	0	-	0
Gross Margin	61.4	62.6	59.5	64.5	64.3	64.0	64.7	64.3	62.6	60.8	58.9	47.2	-7.3	-	-
Total Operating Expenses	582	714	745	641	891	1,169	1,384	1,809	2,211	956	718	225	25	7	56
Operating Profit	122	118	70	90	139	176	203	230	2	-182	-66	-36	-21	-7	-2
Operating Margin	17.3	14.2	8.6	12.3	13.5	13.1	12.8	11.3	0.1	-23.5	-10.0	-18.9	-588.6	-	-3.5
Financing Income/(Expense) - Net	-14	-9	-9	-8	-14	-12	-18	-19	-40	-42	-22	-1	-2	-2	0
Profit before Taxes	115	107	63	85	145	165	188	216	-13	-439	-78	-45	-62	1	4
Income Taxes	21	18	1	5	20	19	28	37	-2	14	5	2	4	-	0
Profit after Tax	86	79	58	70	120	143	160	177	-12	-452	-782	-100	-120	37	11
PAT Margin	12.2	9.6	7.1	9.6	11.6	10.6	10.1	8.7	-0.6	-58.4	-119.9	-53.0	-3,320.9	-	20.0
EPS - Basic - ex Extraordinary Items	7.13	6.62	4.83	5.82	9.97	11.22	12.19	12.13	-0.85	-31.01	-5.66	-3.20	-4.54	0.05	0.11
EPS - Diluted - ex Extraordinary Items	7.11	6.61	4.83	5.82	9.85	11.19	12.15	12.09	-0.85	-31.01	-5.66	-3.20	-4.54	0.05	0.11
EBIT	122	118	70	90	139	176	203	230	2	-182	-66	-36	-21	-7	-2
EBITDA	153	180	159	150	214	266	309	386	169	-67	10	-19	-20	-7	-2
EBITDA Margin	21.8	21.6	19.5	20.5	20.7	19.8	19.5	18.9	7.6	-8.6	1.5	-10.0	-568.7	-	-3.5

Balance Sheet

Abridged

Understanding Balance Sheet

Take Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	2013 Mar 31	R 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	394	460	461	525	626	779	1,178	1,172	1,199	861	1,086	90	35	24	24
Long-Term Investments	1	2	-	5	21	7	7	7	12	7	-	-	-	-	9
Property Plant & Equipment - Net	39	75	80	87	120	168	214	265	339	227	48	30	28	-	-
Total Non-Current Assets	147	160	402	398	589	594	666	1,162	1,284	984	137	134	53	13	12
Total Assets	741	837	862	922	1,215	1,373	1,844	2,334	2,483	1,845	1,223	224	88	36	36
Total Current Liabilities	218	258	262	316	436	336	415	724	660	524	1,007	101	89	16	5
Long Term Debt	123	83	58	1	68	49	55	39	213	161	28	14	7	-	-
Total Non-Current Liabilities	143	113	83	26	100	84	92	83	238	196	36	15	8	0	-
Total Liabilities	361	371	344	342	536	420	507	807	898	720	1,042	116	97	16	5
Total Shareholders' Equity	342	420	470	524	638	911	1,328	1,518	1,575	1,125	181	109	-9	21	31
Minority Interest	38	46	48	56	41	42	8	9	10	0	0	-	-	-	-
Total Equity	380	466	518	580	679	953	1,337	1,527	1,585	1,124	181	109	-9	21	31
Total Liabilities & Equity	741	837	862	922	1,215	1,373	1,844	2,334	2,483	1,845	1,223	224	88	36	36

Cash Flow

Abridged

Understanding Cash Flow Statement

Take Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	C 2015 Mar 31	C 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	132.98	151.60	136.07	139.25	190.71	247.06	278.08	363.37	108.26	-69.85	10.81	18.23	1.12	-9.00	20.06
Working Capital - Increase/(Decrease)	-28.45	-41.99	-36.41	-66.51	-39.96	-190.54	-176.55	-279.65	67.15	174.20	79.29	-2.64	4.85	-7.18	-22.79
Net CF from Operating Activities	104.53	109.60	99.66	72.74	150.75	56.52	101.54	83.72	175.41	104.35	90.10	15.59	5.97	-16.18	-2.73
Capital Expenditures - Net	63.92	73.09	73.68	66.84	163.65	146.96	144.75	190.26	182.49	1.80	31.21	7.30	7.81	-21.98	-
Net CF from Investing Activities	-86.15	-74.89	-95.91	-21.45	-259.03	-135.11	-181.57	-489.85	-236.95	-57.77	-31.38	-2.25	-7.46	22.02	0.00
Dividends Paid - Cash - Total	13.57	22.32	11.96	11.96	14.78	13.09	13.11	28.28	7.11	-	0.01	0.07	0.07	0.04	-
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	172.94	251.35	1.84	0.65	-	-	-	-	-	0.17
Debt - LT & ST - Issuance/(Retirement) - Total	7.77	3.50	10.27	6.94	127.59	-98.61	85.37	151.36	64.00	-52.28	-23.55	-31.10	-8.31	-3.20	-
Net Cash Flow from Financing Activities	-5.80	-18.82	-1.69	-5.02	112.81	61.24	323.61	124.92	57.53	-52.28	-23.56	-31.17	-8.39	-3.24	-0.37
Free Cash Flow to Equity	48.38	40.02	36.25	12.85	114.69	-189.05	42.16	44.82	56.92	50.27	35.34	-22.81	-10.15	2.60	-2.73
Free Operating CF net dividend	27.04	14.19	14.01	-6.06	-66.15	-104.28	-57.50	-137.02	-14.20	101.19	58.88	7.71	-2.02	-16.22	-2.73
Free Operating CF	40.61	36.51	25.97	5.90	-51.37	-91.18	-44.39	-108.74	-7.09	101.19	58.89	7.78	-1.95	-16.18	-2.73

Business Segment Analysis

FY End:

Mar 25

Take Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Assets

Life sciences and support services (100.0%)₹ 36.48 Cr

Operating Income

Life sciences and support services (100.0%)₹ -7.47 Cr

Regional Segment Analysis

FY End:

Mar 25

Take Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Take Ltd. for FY end Mar 25

Historical Segment Analysis

Track how Take Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Life sciences and support services	31	8	8	0

Frequently Asked Questions

What is the revenue of Take Ltd.?

The latest trailing twelve month revenue of Take Ltd. is ₹ 54.19 Cr, reflecting a 3-year CAGR of -34.07%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Take Ltd.?

The latest trailing twelve month net profit (PAT) of Take Ltd. is ₹ 10.85 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Take Ltd.?

The trailing twelve month EBITDA of Take Ltd. is approximately ₹ -1.92 Cr (based on an operating margin of -3.55%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Take Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Take Ltd. is 0.11. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Take Ltd.?

The debt-to-equity ratio of Take Ltd. stands at 0.00. The interest coverage ratio is -5.51x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Take Ltd.?

The estimated book value per share of Take Ltd. is 2.10 (derived from a P/B ratio of 11.77 and market price of ₹ 24.66), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Take Ltd.?

The trailing twelve month operating cash flow of Take Ltd. is ₹ -2.73 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Take Ltd. report consolidated or standalone financials?

Take Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.